Genencell founder sentenced to four years over clinical-trial solicitation

Verifying
  • Seoul High Court sentenced Genencell founder Kang over clinical-trial solicitation and related financial offenses.
  • 600 million Korean won paid to Yang was recognized as compensation for the solicitation.
  • The appellate court reversed the first trial’s acquittal on the 600 million Korean won charge.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Genencell founder sentenced to four years over clinical-trial solicitation - CoinPost Terminal